Davis Jerel - Director, 10%+ Owner at Turnstone Biologics Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
TSBX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Davis Jerel - trading volume in the past year for Turnstone Biologics Corp.

Holdings reported by Davis Jerel for Turnstone Biologics Corp.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 2.73 M Jul 25, 2023 By Versant Venture Capital V, L.P.
Common Stock 275 K Jul 25, 2023 By Versant Vantage II, L.P.
Common Stock 207 K Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Common Stock 90.9 K Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Common Stock 82 K Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Stock Option (Right to Buy) 12.8 K Jun 3, 2024 Direct Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P. Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P. Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP Common Stock
Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P. Common Stock
Series D Preferred Stock 0 Jul 25, 2023 By Versant Vantage II, L.P. Common Stock

Transactions reported by Davis Jerel for Turnstone Biologics Corp.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership